JESSICA ZEHR: Open Payments
NPI 1891028122 · GREENSBORO, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$915 in 37 payments from 12 companies in 2025. Trend: 2023 $567 · 2024 $573 · 2025 $915
Food & beverage: $915
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 5 | $256 |
| ABBVIE INC. | 11 | $239 |
| Celltrion USA Inc. | 4 | $80 |
| GENZYME CORPORATION | 3 | $77 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $67 |
| Ardelyx, Inc. | 4 | $66 |
| Braintree Laboratories, Inc. | 1 | $29 |
| Phathom Pharmaceuticals, Inc. | 2 | $25 |
| Madrigal Pharmaceuticals | 1 | $23 |
| Regeneron Healthcare Solutions, Inc. | 1 | $18 |
Products named: TREMFYA, RINVOQ, DUPIXENT, VEGZELMA, XIFAXAN, IBSRELA, LINZESS, SUTAB.
Industry payments across NC — which companies pay providers there.
